The US Department of Justice is easing federal rules on certain marijuana items by reclassifying the drug as less dangerous. The shift could reduce research hurdles and lessen tax burdens, while aligning federal policy more closely with scientific and medical understanding. Supporters say it may also improve access for patients nationwide, with major implications for the $47 billion cannabis industry.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
